Journals / Medical Science and Discovery / 2019 / Cilt: 6 Sayı: 2

Potential Effects of EGFR Exon 21 L858R Mutations in Lung Cancer

Pages
12–17
Publication Date
2019-02-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to our findings, the EGFR-21 mutation is not associated with histopathological types of lung cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The mainly significant reason in the etiology of lung cancer is smoking, which is important in other environmental pollutants and genetic susceptibility.
📊
Key Findings & Data:Lung cancer is separated two major groups as mainly non-small cell and small cell according to the growth rate, spread, timing of metastasis, response to chemotherapy and radiotherapy.
💡
Conclusion & Impact:Conclusion: According to our findings, the EGFR-21 mutation is not associated with histopathological types of lung cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lung cancer · EGFR gene · exon 21

Abstract

Objective: The mainly significant reason in the etiology of lung cancer is smoking, which is important in other environmental pollutants and genetic susceptibility. Lung cancer is separated two major groups as mainly non-small cell and small cell according to the growth rate, spread, timing of metastasis, response to chemotherapy and radiotherapy. Epidermal growth factor receptor (EGFR) constitutes the highest rate with 50-80% in gene mutations which are prognostic value in lung cancer. Many studies have shown that EGFR is overexpressed in lung cancer. In our study, we aimed to investigate the relationship between EGFR gene exon 21 L858R mutations in lung cancer.Material and Methods: Our sample consisted of a healthy group of 190 healthy volunteers with the same age and gender characteristics as the patient group of 178 patients who were diagnosed as lung cancer in the Mersin University Medical Faculty Oncology clinic. The DNAs were obtained according to the standard salt precipitation method. Mutation detection and genotyping analyzes were identified by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analyzes.Results: Smoking was one of the other risk factors for lung cancer, 130 (68.33%) in the control group and 156 (87.5%) in the lung cancer group. 27 person of the lung cancer (15%) were female and 151 (85%) were male. In the control group, 92 people (48.33%) were in the wild genotype and 98 persons were in the mutant genotype (51.66%). In the lung cancer group 80 (45%) were wild-type and 98 (55%) were mutant genotypes. According to the histopathological types of lung cancer, EGFR-21 mutation heterozygous or homozygous carriers are proportionally compatible (p = 0.90). Conclusion: According to our findings, the EGFR-21 mutation is not associated with histopathological types of lung cancer.

🔖

Cite This Article

EKER, E. D., ARICAN, A., ARPACI, R. B., NAYIR, E., ATA, A., ERAS, N., YILDIRIM, D. D., AKBAŞ, E. (2019). Potential Effects of EGFR Exon 21 L858R Mutations in Lung Cancer. Medical Science and Discovery, Cilt: 6 Sayı: 2, 12–17. https://ajindex.com/articles/1002977

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Köktürk N, Kırısoğlu CE, Öztürk C. Akciğer kanseri moleküler biyolojisi. Solunum 2003; 5:127-38
  2. Sasaki K, Kawauchi S. Molecular cytogenetic analysis of solid tumors. J Orthop Sci 2003; 8:457-9. 3. http://www.who.int/cancer/en/ Accessed 21.11.2018 4. www.cancerquest.org Accessed 21.11.2018 5. Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29
  3. Akciğer ve Plevra Maligniteleri Çalışma Grubu. Akciğer kanseri tanı ve tedavi rehberi. Toraks Dergisi 2006; 7:1-37
  4. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132:29-55
  5. Grenle RT, Murray T, Bolden, S, Wingo PA. Cancer statistics 2000. CA, Cancer J Clin 2000; 50:7-33
  6. Kumar V, Cotran RS, Robbins SL. Temel Patoloji, 2000. 6. baskı, NobelTıp Kitabevi, İstanbul. 10. www.patoloji.gen.tr Accessed 21.11.2018 11. Cooper WA, Lam DC, O'Toole SA, Minna JD. Molecular biology of lung cancer. J Thorac Dis. 2013; 5:479-90
  7. Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS Journal 2010; 277(2): 301-308
  8. Siegelin MD, Borczuk AC. Epidermal growth factor receptor mutations in lung adenocarcinoma. Laboratory Investigation. 2014; 94:129–137
  9. Bozetti C, Tiseo M, Lagrasta C, Nizzolli R, Guazzi A, et al. Comparison between epidermal growth factor receptor gene expression in primary non small cell lung cancer and in fine-needle aspirate from distant metastatic sites. J Thorac Oncol. 2008; 3(1):18-22
  10. Takano T, Ohe Y, Sakamoto H et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005; 23:6829-37
  11. Hung WY, Chang JH, Cheng Y, Chen CK, Chen JQ, Hua KT, Cheng CW, Hsiao M, Chung CL, Lee WJ, Chien MH. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities. Cell Physiol Biochem. 2018; 51(1):337-355
  12. Agustoni F, Suda K, Yu H, Ren S, Rivard CJ, Ellison K, Caldwell C Jr, Rozeboom L, Brovsky K, Hirsch FR. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis. Cancer Treat Rev. 2018; 4(72):15-27
  13. Han SW, Kim TY, Hwang PG et al. Predictive and prognostic impact of epidermal gr